nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0394	0.0452	CbGbCtD
Promazine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.037	0.0425	CbGbCtD
Promazine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0363	0.0417	CbGbCtD
Promazine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0342	0.0392	CbGbCtD
Promazine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0342	0.0392	CbGbCtD
Promazine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0335	0.0384	CbGbCtD
Promazine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0335	0.0384	CbGbCtD
Promazine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0327	0.0376	CbGbCtD
Promazine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0309	0.0355	CbGbCtD
Promazine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0308	0.0353	CbGbCtD
Promazine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0308	0.0353	CbGbCtD
Promazine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0289	0.0332	CbGbCtD
Promazine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.028	0.0322	CbGbCtD
Promazine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0278	0.0319	CbGbCtD
Promazine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0278	0.0319	CbGbCtD
Promazine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0259	0.0297	CbGbCtD
Promazine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0254	0.0291	CbGbCtD
Promazine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0254	0.0291	CbGbCtD
Promazine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0243	0.0279	CbGbCtD
Promazine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.024	0.0276	CbGbCtD
Promazine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0234	0.0269	CbGbCtD
Promazine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0233	0.0268	CbGbCtD
Promazine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0211	0.0242	CbGbCtD
Promazine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0211	0.0242	CbGbCtD
Promazine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0202	0.0232	CbGbCtD
Promazine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.019	0.0218	CbGbCtD
Promazine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0179	0.0205	CbGbCtD
Promazine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0179	0.0205	CbGbCtD
Promazine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0162	0.0186	CbGbCtD
Promazine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0162	0.0186	CbGbCtD
Promazine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.014	0.016	CbGbCtD
Promazine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0136	0.0156	CbGbCtD
Promazine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0123	0.0141	CbGbCtD
Promazine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0123	0.0141	CbGbCtD
Promazine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0118	0.0135	CbGbCtD
Promazine—DRD1—nerve—acquired immunodeficiency syndrome	0.00372	0.0601	CbGeAlD
Promazine—DRD2—nerve—acquired immunodeficiency syndrome	0.0022	0.0355	CbGeAlD
Promazine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00171	0.0277	CbGeAlD
Promazine—CHRM5—skin of body—acquired immunodeficiency syndrome	0.00159	0.0257	CbGeAlD
Promazine—HTR2A—nerve—acquired immunodeficiency syndrome	0.00145	0.0234	CbGeAlD
Promazine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.0014	0.0226	CbGeAlD
Promazine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00133	0.0215	CbGeAlD
Promazine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00129	0.0208	CbGeAlD
Promazine—DRD4—brain—acquired immunodeficiency syndrome	0.00127	0.0205	CbGeAlD
Promazine—CHRM4—nervous system—acquired immunodeficiency syndrome	0.00126	0.0203	CbGeAlD
Promazine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00123	0.0199	CbGeAlD
Promazine—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.00121	0.0195	CbGeAlD
Promazine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.0011	0.0177	CbGeAlD
Promazine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00101	0.0164	CbGeAlD
Promazine—CHRM5—nervous system—acquired immunodeficiency syndrome	0.000981	0.0159	CbGeAlD
Promazine—CHRM4—brain—acquired immunodeficiency syndrome	0.00096	0.0155	CbGeAlD
Promazine—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.000945	0.0153	CbGeAlD
Promazine—DRD2—retina—acquired immunodeficiency syndrome	0.000909	0.0147	CbGeAlD
Promazine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000897	0.0145	CbGeAlD
Promazine—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.000877	0.0142	CbGeAlD
Promazine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000863	0.014	CbGeAlD
Promazine—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.000844	0.0137	CbGeAlD
Promazine—DRD1—nervous system—acquired immunodeficiency syndrome	0.000836	0.0135	CbGeAlD
Promazine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000805	0.013	CbGeAlD
Promazine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000771	0.0125	CbGeAlD
Promazine—CHRM5—brain—acquired immunodeficiency syndrome	0.00075	0.0121	CbGeAlD
Promazine—CHRM3—digestive system—acquired immunodeficiency syndrome	0.000709	0.0115	CbGeAlD
Promazine—ADRA1B—brain—acquired immunodeficiency syndrome	0.000685	0.0111	CbGeAlD
Promazine—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000674	0.0109	CbGeAlD
Promazine—ADRA1D—brain—acquired immunodeficiency syndrome	0.00067	0.0108	CbGeAlD
Promazine—CHRM1—lung—acquired immunodeficiency syndrome	0.000662	0.0107	CbGeAlD
Promazine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000659	0.0107	CbGeAlD
Promazine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000659	0.0107	CbGeAlD
Promazine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000649	0.0105	CbGeAlD
Promazine—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000649	0.0105	CbGeAlD
Promazine—DRD1—brain—acquired immunodeficiency syndrome	0.000639	0.0103	CbGeAlD
Promazine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000628	0.0102	CbGeAlD
Promazine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000625	0.0101	CbGeAlD
Promazine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000621	0.01	CbGeAlD
Promazine—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000613	0.00991	CbGeAlD
Promazine—HTR2A—retina—acquired immunodeficiency syndrome	0.0006	0.0097	CbGeAlD
Promazine—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.00059	0.00955	CbGeAlD
Promazine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000582	0.00942	CbGeAlD
Promazine—CHRM3—nervous system—acquired immunodeficiency syndrome	0.000549	0.00887	CbGeAlD
Promazine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000539	0.00871	CbGeAlD
Promazine—DRD2—lung—acquired immunodeficiency syndrome	0.000533	0.00862	CbGeAlD
Promazine—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.000528	0.00854	CbGeAlD
Promazine—CHRM2—brain—acquired immunodeficiency syndrome	0.000515	0.00833	CbGeAlD
Promazine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000513	0.0083	CbGeAlD
Promazine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000511	0.00827	CbGeAlD
Promazine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000504	0.00815	CbGeAlD
Promazine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000504	0.00815	CbGeAlD
Promazine—HTR2C—brain—acquired immunodeficiency syndrome	0.000496	0.00802	CbGeAlD
Promazine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000494	0.00798	CbGeAlD
Promazine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000487	0.00788	CbGeAlD
Promazine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000485	0.00784	CbGeAlD
Promazine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000475	0.00769	CbGeAlD
Promazine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000472	0.00763	CbGeAlD
Promazine—CHRM1—brain—acquired immunodeficiency syndrome	0.000469	0.00758	CbGeAlD
Promazine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000455	0.00735	CbGeAlD
Promazine—CYP1A2—lung—acquired immunodeficiency syndrome	0.00045	0.00727	CbGeAlD
Promazine—HRH1—vagina—acquired immunodeficiency syndrome	0.000445	0.0072	CbGeAlD
Promazine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000437	0.00707	CbGeAlD
Promazine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000421	0.00681	CbGeAlD
Promazine—HRH1—lung—acquired immunodeficiency syndrome	0.000421	0.00681	CbGeAlD
Promazine—CHRM3—brain—acquired immunodeficiency syndrome	0.000419	0.00678	CbGeAlD
Promazine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000414	0.00669	CbGeAlD
Promazine—HTR2A—blood—acquired immunodeficiency syndrome	0.000401	0.00649	CbGeAlD
Promazine—HRH1—nervous system—acquired immunodeficiency syndrome	0.00039	0.00631	CbGeAlD
Promazine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00039	0.0063	CbGeAlD
Promazine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000387	0.00625	CbGeAlD
Promazine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000385	0.00623	CbGeAlD
Promazine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000383	0.00619	CbGeAlD
Promazine—DRD2—brain—acquired immunodeficiency syndrome	0.000377	0.0061	CbGeAlD
Promazine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000375	0.00607	CbGeAlD
Promazine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000372	0.00601	CbGeAlD
Promazine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000371	0.00601	CbGeAlD
Promazine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000369	0.00596	CbGeAlD
Promazine—HTR2A—lung—acquired immunodeficiency syndrome	0.000352	0.00569	CbGeAlD
Promazine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000326	0.00527	CbGeAlD
Promazine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000314	0.00507	CbGeAlD
Promazine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000302	0.00488	CbGeAlD
Promazine—HRH1—brain—acquired immunodeficiency syndrome	0.000298	0.00482	CbGeAlD
Promazine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000293	0.00473	CbGeAlD
Promazine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00029	0.00469	CbGeAlD
Promazine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000288	0.00466	CbGeAlD
Promazine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000283	0.00457	CbGeAlD
Promazine—HTR2A—brain—acquired immunodeficiency syndrome	0.000249	0.00403	CbGeAlD
Promazine—Oxcarbazepine—ALB—acquired immunodeficiency syndrome	0.000142	0.218	CrCbGaD
Promazine—Acepromazine—ALB—acquired immunodeficiency syndrome	0.000107	0.165	CrCbGaD
Promazine—Thioproperazine—ALB—acquired immunodeficiency syndrome	0.000105	0.161	CrCbGaD
Promazine—Pipotiazine—ALB—acquired immunodeficiency syndrome	0.000103	0.159	CrCbGaD
Promazine—Clomipramine—ALB—acquired immunodeficiency syndrome	8.15e-05	0.125	CrCbGaD
Promazine—Chlorpromazine—ALB—acquired immunodeficiency syndrome	5.59e-05	0.086	CrCbGaD
Promazine—Amitriptyline—ALB—acquired immunodeficiency syndrome	5.53e-05	0.085	CrCbGaD
Promazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.96e-05	0.000446	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.95e-05	0.000444	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.95e-05	0.000444	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.93e-05	0.00044	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.91e-05	0.000438	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.91e-05	0.000438	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.91e-05	0.000437	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.89e-05	0.000434	CbGpPWpGaD
Promazine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.88e-05	0.000434	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.85e-05	0.000428	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.83e-05	0.000425	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.83e-05	0.000425	CbGpPWpGaD
Promazine—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.82e-05	0.000424	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.8e-05	0.000422	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.8e-05	0.000422	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.8e-05	0.000421	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.8e-05	0.00042	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.79e-05	0.00042	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.79e-05	0.00042	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.79e-05	0.00042	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.79e-05	0.000419	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.78e-05	0.000418	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.78e-05	0.000418	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.76e-05	0.000415	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.76e-05	0.000415	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.75e-05	0.000414	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.75e-05	0.000414	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.74e-05	0.000413	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.74e-05	0.000412	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.74e-05	0.000411	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.71e-05	0.000407	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.7e-05	0.000406	CbGpPWpGaD
Promazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.69e-05	0.000404	CbGpPWpGaD
Promazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.68e-05	0.000404	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.68e-05	0.000402	CbGpPWpGaD
Promazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.68e-05	0.000402	CbGpPWpGaD
Promazine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.67e-05	0.000401	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.66e-05	0.0004	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.66e-05	0.0004	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.64e-05	0.000397	CbGpPWpGaD
Promazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.63e-05	0.000396	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.62e-05	0.000394	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.62e-05	0.000394	CbGpPWpGaD
Promazine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	2.59e-05	0.000389	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.59e-05	0.000389	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.56e-05	0.000386	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.56e-05	0.000386	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.56e-05	0.000385	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.55e-05	0.000383	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.55e-05	0.000383	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.54e-05	0.000382	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.54e-05	0.000382	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.53e-05	0.00038	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.53e-05	0.00038	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.52e-05	0.000379	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.52e-05	0.000379	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.52e-05	0.000379	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.51e-05	0.000377	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.51e-05	0.000377	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.51e-05	0.000377	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.5e-05	0.000376	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.5e-05	0.000376	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.5e-05	0.000376	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.49e-05	0.000375	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.49e-05	0.000374	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.48e-05	0.000374	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.48e-05	0.000373	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.47e-05	0.000372	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.46e-05	0.00037	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.45e-05	0.000369	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.42e-05	0.000364	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.36e-05	0.000355	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.33e-05	0.00035	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.32e-05	0.000349	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.32e-05	0.000349	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.32e-05	0.000348	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.31e-05	0.000348	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.31e-05	0.000347	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.3e-05	0.000346	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.3e-05	0.000345	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.29e-05	0.000345	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.29e-05	0.000344	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.28e-05	0.000343	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.28e-05	0.000343	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.28e-05	0.000343	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.27e-05	0.000342	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.27e-05	0.000342	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.27e-05	0.000342	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.27e-05	0.000342	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.25e-05	0.000338	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.25e-05	0.000338	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.24e-05	0.000337	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.22e-05	0.000333	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.21e-05	0.000333	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.18e-05	0.000328	CbGpPWpGaD
Promazine—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.18e-05	0.000328	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.18e-05	0.000328	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.18e-05	0.000327	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.18e-05	0.000327	CbGpPWpGaD
Promazine—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.15e-05	0.000323	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.14e-05	0.000321	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.12e-05	0.000319	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.11e-05	0.000318	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.1e-05	0.000316	CbGpPWpGaD
Promazine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	2.1e-05	0.000316	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.1e-05	0.000315	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.09e-05	0.000314	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.09e-05	0.000314	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.08e-05	0.000313	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.08e-05	0.000313	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.06e-05	0.00031	CbGpPWpGaD
Promazine—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.06e-05	0.00031	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.06e-05	0.000309	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.02e-05	0.000304	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.02e-05	0.000304	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.01e-05	0.000302	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.01e-05	0.000302	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2e-05	0.0003	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2e-05	0.0003	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.99e-05	0.0003	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.98e-05	0.000298	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.98e-05	0.000297	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.98e-05	0.000297	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.97e-05	0.000296	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.97e-05	0.000296	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.97e-05	0.000296	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.96e-05	0.000295	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.96e-05	0.000295	CbGpPWpGaD
Promazine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.96e-05	0.000295	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.96e-05	0.000294	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.96e-05	0.000294	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.95e-05	0.000294	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.94e-05	0.000292	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.94e-05	0.000292	CbGpPWpGaD
Promazine—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.94e-05	0.000291	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.93e-05	0.000291	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.93e-05	0.000291	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.91e-05	0.000288	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.91e-05	0.000287	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.87e-05	0.000281	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.82e-05	0.000274	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.8e-05	0.00027	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.8e-05	0.00027	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.8e-05	0.00027	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.78e-05	0.000268	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.76e-05	0.000264	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.73e-05	0.00026	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.7e-05	0.000256	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.68e-05	0.000252	CbGpPWpGaD
Promazine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.67e-05	0.000251	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.66e-05	0.000249	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.63e-05	0.000245	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.61e-05	0.000242	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.56e-05	0.000234	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.53e-05	0.00023	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.52e-05	0.000229	CbGpPWpGaD
Promazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.52e-05	0.000229	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.5e-05	0.000226	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.5e-05	0.000226	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.5e-05	0.000225	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.49e-05	0.000225	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000224	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.49e-05	0.000224	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.48e-05	0.000223	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000223	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000222	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.48e-05	0.000222	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.47e-05	0.000221	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.47e-05	0.000221	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.47e-05	0.000221	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.46e-05	0.000219	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.46e-05	0.000219	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.45e-05	0.000219	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.45e-05	0.000219	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.45e-05	0.000218	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.45e-05	0.000218	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.45e-05	0.000217	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000215	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000215	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.38e-05	0.000207	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.37e-05	0.000206	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.000204	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.000203	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.35e-05	0.000202	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.000202	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.35e-05	0.000202	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.34e-05	0.000202	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.33e-05	0.0002	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.33e-05	0.000199	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.33e-05	0.000199	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000199	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000199	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000198	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.31e-05	0.000197	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.3e-05	0.000196	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.3e-05	0.000195	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.3e-05	0.000195	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.23e-05	0.000185	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.2e-05	0.000181	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.17e-05	0.000176	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.16e-05	0.000175	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.15e-05	0.000173	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.15e-05	0.000173	CbGpPWpGaD
Promazine—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	1.14e-05	0.000172	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.1e-05	0.000166	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.1e-05	0.000165	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.05e-05	0.000158	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	1.05e-05	0.000158	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.05e-05	0.000158	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.04e-05	0.000156	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.03e-05	0.000155	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.01e-06	0.000135	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.96e-06	0.000135	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.62e-06	0.00013	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.58e-06	0.000129	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.95e-06	0.00012	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.91e-06	0.000119	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.82e-06	0.000118	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.81e-06	0.000117	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.78e-06	0.000117	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.78e-06	0.000117	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.77e-06	0.000117	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.76e-06	0.000117	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.74e-06	0.000116	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.72e-06	0.000116	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.68e-06	0.000115	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.66e-06	0.000115	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.64e-06	0.000115	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.62e-06	0.000115	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	7.44e-06	0.000112	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.12e-06	0.000107	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.08e-06	0.000106	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.87e-06	0.000103	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.78e-06	0.000102	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	6.78e-06	0.000102	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.49e-06	9.76e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.19e-06	9.3e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.11e-06	9.18e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.79e-06	8.71e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.29e-06	7.96e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.07e-06	7.62e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.67e-06	7.03e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.6e-06	6.91e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.59e-06	6.9e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.57e-06	6.88e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.56e-06	6.85e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.51e-06	6.79e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.5e-06	6.77e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	4.47e-06	6.72e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.18e-06	6.29e-05	CbGpPWpGaD
